These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 20089008)
21. Occlusion of PFO with a dedicated adjustable device: influence on one year outcome. Kleber FX; Winkelmann A; Stretz A; Sonntag SM; Bruch L; Rademacher G; Sparenberg P; Schmehl I EuroIntervention; 2010 Aug; 6(3):367-70. PubMed ID: 20884416 [TBL] [Abstract][Full Text] [Related]
22. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism. Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745 [TBL] [Abstract][Full Text] [Related]
23. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525 [TBL] [Abstract][Full Text] [Related]
24. Is transcatheter closure better than medical therapy for cryptogenic stroke with patent foramen ovale? A meta-analysis of randomised trials. Nagaraja V; Raval J; Eslick GD; Burgess D; Denniss AR Heart Lung Circ; 2013 Nov; 22(11):903-9. PubMed ID: 24035325 [TBL] [Abstract][Full Text] [Related]
25. Long-term results after fluoroscopy-guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Wahl A; Kunz M; Moschovitis A; Nageh T; Schwerzmann M; Seiler C; Mattle HP; Windecker S; Meier B Heart; 2008 Mar; 94(3):336-41. PubMed ID: 17639093 [TBL] [Abstract][Full Text] [Related]
26. Patent foramen ovale--assessment and treatment. Irwin B; Ray S Cardiovasc Ther; 2012 Jun; 30(3):e128-35. PubMed ID: 21883994 [TBL] [Abstract][Full Text] [Related]
27. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. Carroll JD; Saver JL; Thaler DE; Smalling RW; Berry S; MacDonald LA; Marks DS; Tirschwell DL; N Engl J Med; 2013 Mar; 368(12):1092-100. PubMed ID: 23514286 [TBL] [Abstract][Full Text] [Related]
28. Periprocedural and late complications after percutaneous closure of patent foramen ovale: a single centre experience. Węglarz P; Konarska Kuszewska E; Spisak Borowska K; Machowski J; Drzewiecka-Gerber A; Kuszewski P; Jackson CL; Opala G; Trusz Gluza M Kardiol Pol; 2012; 70(5):478-84. PubMed ID: 22623240 [TBL] [Abstract][Full Text] [Related]
29. Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale. Rodés-Cabau J; Mineau S; Marrero A; Houde C; Mackey A; Côté JM; Chetaille P; Delisle G; Bertrand OF; Rivest D Am J Cardiol; 2008 Mar; 101(5):688-92. PubMed ID: 18308022 [TBL] [Abstract][Full Text] [Related]
30. The percutaneous closure of patent foramen ovale (PFO): impact on the quality of life. Evola S; Kauroo BA; Trovato RL; Alioto L; D'Amico G; Fonte G; Andolina G; Novo S; Assennato P Int J Cardiol; 2013 Sep; 168(2):1622-3. PubMed ID: 23398832 [No Abstract] [Full Text] [Related]
31. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the U.S. multicenter clinical trial. Hong TE; Thaler D; Brorson J; Heitschmidt M; Hijazi ZM; Catheter Cardiovasc Interv; 2003 Dec; 60(4):524-8. PubMed ID: 14624434 [TBL] [Abstract][Full Text] [Related]
32. Transcatheter closure of patent foramen ovale with the Spider patent foramen ovale occluder: a prospective, single-center trial. Zhang CJ; Huang YG; Huang XS; Huang T; Huang WH; Shen JJ; Xun ZR Chin Med J (Engl); 2010 Apr; 123(7):834-7. PubMed ID: 20497673 [TBL] [Abstract][Full Text] [Related]
33. Percutaneous closure of patent foramen ovale and atrial septal defect: procedure outcome and medium-term follow-up. Egred M; Andron M; Albouaini K; Alahmar A; Grainger R; Morrison WL J Interv Cardiol; 2007 Oct; 20(5):395-401. PubMed ID: 17880337 [TBL] [Abstract][Full Text] [Related]
34. Percutaneous closure of patent foramen ovale in patients with presumed paradoxical embolism: periprocedural results and midterm risk of recurrent neurologic events. Balbi M; Casalino L; Gnecco G; Bezante GP; Pongiglione G; Marasini M; Del Sette M; Barsotti A Am Heart J; 2008 Aug; 156(2):356-60. PubMed ID: 18657668 [TBL] [Abstract][Full Text] [Related]
35. Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies. Abaci A; Unlu S; Alsancak Y; Kaya U; Sezenoz B Catheter Cardiovasc Interv; 2013 Dec; 82(7):1123-38. PubMed ID: 23412921 [TBL] [Abstract][Full Text] [Related]
36. Intrapulmonary shunt is a potentially unrecognized cause of ischemic stroke and transient ischemic attack. Abushora MY; Bhatia N; Alnabki Z; Shenoy M; Alshaher M; Stoddard MF J Am Soc Echocardiogr; 2013 Jul; 26(7):683-90. PubMed ID: 23669596 [TBL] [Abstract][Full Text] [Related]
37. Trans-catheter treatment of residual leak after PFO device closure. Santoro G; Giugno L; Gaio G; Capogrosso C; Iacono C; Russo MG Int J Cardiol; 2014 Jun; 174(1):e13-5. PubMed ID: 24767132 [No Abstract] [Full Text] [Related]
38. Relationship between mean platelet volume and ischemic stroke in patients with patent foramen ovale. Bayar N; Küçükseymen S; Erkal Z; Güven R; Köklü E; Üreyen ÇM; Arslan Ş Turk Kardiyol Dern Ars; 2017 Jan; 45(1):9-15. PubMed ID: 28106015 [TBL] [Abstract][Full Text] [Related]
39. Increased prevalence of posttraumatic stress disorder in patients after transient ischemic attack. Kiphuth IC; Utz KS; Noble AJ; Köhrmann M; Schenk T Stroke; 2014 Nov; 45(11):3360-6. PubMed ID: 25278556 [TBL] [Abstract][Full Text] [Related]
40. May-Thurner Syndrome and Patent Foramen Ovale: A Rare Etiology of Cryptogenic Stroke. Phelps BJ; Boutin O; Patel U; King C Cureus; 2019 Aug; 11(8):e5468. PubMed ID: 31641564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]